ACADIA INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Acadi...
May 09 2015 - 2:00PM
Faruqi & Faruqi, LLP, a leading national securities law firm,
reminds investors in Acadia Pharmaceuticals, Inc. (“Acadia” or the
“Company”) (Nasdaq:ACAD) of the May 12, 2015 deadline to seek the
role of lead plaintiff in a federal securities class action lawsuit
filed against Acadia and certain executives of the Company.
A complaint has been filed in the United States District Court
for the Southern District of California on behalf of all persons
who purchased Acadia common stock during the period of February 26,
2015 to March 11, 2015 (the “Class Period”).
The complaint alleges that the Company and certain executives
violated the federal securities laws with respect to its statements
concerning its business, operations, and prospects.
Specifically, the action alleges that on March 11, 2015, Acadia
disclosed that it will delay submission of its New Drug Application
for its experimental Parkinson’s disease drug, nuplazid, from this
quarter to sometime in the second half of the year. As well, Acadia
announced that its long-time Chief Executive Officer will be
stepping down.
Following this news, Acadia shares declined by $9.94 per share,
or more than 22%, to close on March 12, 2015 at $34.82 per
share.
Request more information now by clicking here:
www.faruqilaw.com/ACAD. There is no cost or obligation to
you.
Take Action
If you invested in Acadia stock or options between February 26
and March 11, 2015 and would like to discuss your legal rights,
visit www.faruqilaw.com/ACAD. You can also contact us by calling
Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by
sending an e-mail to rgonnello@faruqilaw.com. Faruqi & Faruqi,
LLP also encourages anyone with information regarding Acadia’s
conduct to contact the firm, including whistleblowers, former
employees, shareholders and others. Attorney Advertising. The law
firm responsible for this advertisement is Faruqi & Faruqi, LLP
(www.faruqilaw.com). Prior results do not guarantee or predict a
similar outcome with respect to any future matter. We welcome the
opportunity to discuss your particular case. All communications
will be treated in a confidential manner.
CONTACT:
FARUQI & FARUQI, LLP
369 Lexington Avenue, 10th Floor
New York, NY 10017
Attn: Richard Gonnello, Esq.
rgonnello@faruqilaw.com
Telephone: (877) 247-4292 or (212) 983-9330
Acadia Pharmaceuticals (NASDAQ:ACAD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Acadia Pharmaceuticals (NASDAQ:ACAD)
Historical Stock Chart
From Sep 2023 to Sep 2024